Alteration of endothelial function markers in women with gestational diabetes and their fetuses

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 26, Issue 5, 2013, Pages 507-512

  Mordwinkin, Nicholas M ^a   Ouzounian, Joseph G ^b   Yedigarova, Larisa ^b   Montoro, Martin N ^b   Louie, Stan G ^a   Rodgers, Kathleen E ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Endothelial dysfunction; Gestational diabetes mellitus; Oxidative stress

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEMOGLOBIN A1C; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; NITRIC OXIDE; NITRITE; PROTEIN P22; SUPEROXIDE DISMUTASE; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CASE CONTROL STUDY; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL PROGENITOR CELL; FEMALE; FETUS; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; MATERNAL BLOOD; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PILOT STUDY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL CORD BLOOD;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CELL COUNT; DIABETES, GESTATIONAL; ENDOTHELIUM, VASCULAR; FEMALE; FETAL BLOOD; FETUS; HUMANS; HYPERGLYCEMIA; INTERCELLULAR ADHESION MOLECULE-1; NADPH OXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; PREGNANCY; RNA, MESSENGER; STEM CELLS; SUPEROXIDE DISMUTASE; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84874089235     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2012.736564     Document Type: Article

References (27)

1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010;121:948-954.
2. de Jager J, Dekker JM, Kooy A, Kostense PJ, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD. Endothelial dysfunction and low-grade inflammation explain much of the excess cardiovascular mortality in individuals with type 2 diabetes: the Hoorn Study. Arterioscler Thromb Vasc Biol 2006;26:1086-1093.
3. Deanfield J, Donald A, Ferri C, Giannattasio C, Halcox J, Halligan S, Lerman A, et al.; Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005;23:7-17.
4. Calles-Escandon J, Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev 2001;22:36-52.
5. Meigs JB, Hu FB, Rifai N, Manson JE. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 2004;291:1978-1986.
6. Hod M, Yogev Y. Goals of metabolic management of gestational diabetes: is it all about the sugar? Diabetes Care 2007;30 Suppl 2:S180-S187.
7. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, Channon KM. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 2002;105:1656-1662.
8. Sheetz MJ, King GL. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 2002;288:2579-2588.
9. Bitar MS, Wahid S, Mustafa S, Al-Saleh E, Dhaunsi GS, Al-Mulla F. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes. Eur J Pharmacol 2005;511:53-64.
10. Mordwinkin NM, Meeks CJ, Jadhav SS, Espinoza T, Roda N, diZerega GS, Louie SG, Rodgers KE. Angiotensin-(1-7) administration reduces oxidative stress in diabetic bone marrow. Endocrinology 2012;153:2189-2197.
11. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-967.
12. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, Levine JP, Gurtner GC. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002;106:2781-2786.
13. Loomans CJ, de Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C, de Boer HC, Verhaar MC, et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004;53:195-199.
14. Gibson JL, Lyall F, Boswell F, Young A, Maccuish AC, Greer IA. Circulating cell adhesion molecule concentrations in diabetic women during pregnancy. Obstet Gynecol 1997;90:874-879.
15. Acosta JC, Haas DM, Saha CK, Dimeglio LA, Ingram DA, Haneline LS. Gestational diabetes mellitus alters maternal and neonatal circulating endothelial progenitor cell subsets. Am J Obstet Gynecol 2011;204:254.e8-254. e15.
16. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26 Suppl 1:S5-S20.
17. Jovanovic L, Pettitt DJ. Gestational diabetes mellitus. JAMA 2001;286:2516-2518.
18. Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, Ochoa C, et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes 2002;51:2796-2803.
19. Schaefer-Graf UM, Pawliczak J, Passow D, Hartmann R, Rossi R, Bührer C, Harder T, et al. Birth weight and parental BMI predict overweight in children from mothers with gestational diabetes. Diabetes Care 2005;28:1745-1750.
20. Ouzounian JG, Hernandez GD, Korst LM, Montoro MM, Battista LR, Walden CL, Lee RH. Pre-pregnancy weight and excess weight gain are risk factors for macrosomia in women with gestational diabetes. J Perinatol 2011;31:717-721.
21. Jensen DM, Damm P, Sørensen B, Mølsted-Pedersen L, Westergaard JG, Klebe J, Beck-Nielsen H. Clinical impact of mild carbohydrate intolerance in pregnancy: a study of 2904 nondiabetic Danish women with risk factors for gestational diabetes mellitus. Am J Obstet Gynecol 2001;185:413-419.
22. Kautzky-Willer A, Fasching P, Jilma B, Waldhäusl W, Wagner OF. Persistent elevation and metabolic dependence of circulating E-selectin after delivery in women with gestational diabetes mellitus. J Clin Endocrinol Metab 1997;82:4117-4121.
23. Krauss T, Emons G, Kuhn W, Augustin HG. Predictive value of routine circulating soluble endothelial cell adhesion molecule measurements during pregnancy. Clin Chem 2002;48:1418-1425.
24. Bo S, Valpreda S, Menato G, Bardelli C, Botto C, Gambino R, Rabbia C, Durazzo M, Cassader M, Massobrio M, Pagano G. Should we consider gestational diabetes a vascular risk factor? Atherosclerosis 2007;195:72-79.
25. Hillier TA, Pedula KL, Schmidt MM, Mullen JA, Charles MA, Pettitt DJ. Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia. Diabetes Care 2007;30:2287-2292.
26. Glowinska B, Urban M, Peczynska J, Florys B. Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes. Metab Clin Exp 2005;54:1020-1026.
27. Sobngwi E, Boudou P, Mauvais-Jarvis F, Leblanc H, Velho G, Vexiau P, Porcher R, et al. Effect of a diabetic environment in utero on predisposition to type 2 diabetes. Lancet 2003;361:1861-1865.